Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
Common Hereditary Cancer Screening Panel PreventionGenetics United States | 94 | 55 |
|
Centogene AG - the Rare Disease Company Germany | 114 | 68 |
|
Centogene AG - the Rare Disease Company Germany | 156 | 107 |
|
SDHC - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
Invitae Multi-Cancer + RNA Panel Invitae United States | 143 | 63 |
|
Invitae Common Hereditary Cancers + RNA Panel Invitae United States | 114 | 47 |
|
PreventionGenetics United States | 36 | 19 |
|
Invitae Nuclear Mitochondrial Disorders Panel Invitae United States | 394 | 319 |
|
Invitae United States | 409 | 164 |
|
Invitae United States | 160 | 62 |
|
Invitae 78 Gene Actionable Disorders Panel Invitae United States | 220 | 75 |
|
Variant Resolution Test for CustomNext-Cancer® (+RNAinsight®) Ambry Genetics United States | 147 | 18 |
|
Variant Resolution Test for RenalNext® (+RNAinsight®) Ambry Genetics United States | 57 | 7 |
|
Variant Resolution Test for PGLNext® (+RNAinsight®) Ambry Genetics United States | 26 | 1 |
|
Variant Resolution Test for CancerNext-Expanded® (+RNAinsight®) Ambry Genetics United States | 141 | 18 |
|
SDHC - hereditary paraganglioma and pheochromocytoma Translational Metabolic Laboratory Radboud University Medical Centre Netherlands | 2 | 1 |
|
PreventionGenetics United States | 78 | 64 |
|
Ambry Genetics United States | 57 | 20 |
|
Ambry Genetics United States | 26 | 14 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.